🤖 Healthcare - Reducing ICH Transfer Times
This article discusses a hospital system's implementation of Viz.ai to reduce intracerebral hemorrhage (ICH) transfer times by almost 50%. The integration into the NEMAT workflow is detailed.
Key Points:
• Significant reduction in ICH transfer times.
• Successful integration of Viz.ai into the NEMAT workflow.
• Improved efficiency and patient care in ICH management.
🔗 Resources:
• Viz.ai ↗ - AI-powered stroke care platform
Image
🤖 Healthcare - AI in Cancer Detection and Management
This article discusses the use of AI in earlier cancer detection and more effective management, as highlighted by Alverno Laboratories CEO Sam Terese. The article mentions Alverno, UPMC, and other organizations' involvement.
Key Points:
• AI offers potential for earlier cancer detection.
• AI can improve cancer management effectiveness.
• Increased efficiency and accuracy in cancer diagnosis and treatment.
Image
✨ Oncology - DESTINY-Breast09 LBA1008 Results
This article summarizes the results of the DESTINY-Breast09 LBA1008 study presented at ASCO25, focusing on the treatment of HER2-positive metastatic breast cancer. Key findings regarding median progression-free survival and safety are highlighted.
Key Points:
• Median PFS significantly improved with T-DXd + P compared to THP.
• Similar safety profiles observed, with comparable ILD rates.
• Practice-changing results presented by Sara M. Tolaney et al.
Image
Image
Image
Image
🤖 Oncology - CheckMate 816 5-Year Overall Survival
This article presents the 5-year overall survival (OS) data from the CheckMate 816 trial, focusing on neoadjuvant nivolumab plus chemotherapy in non-small cell lung cancer (NSCLC). The impact of PD-L1 status on survival is discussed.
Key Points:
• Improved 5-year OS with neoadjuvant nivolumab + CT compared to CT alone.
• pCR strongly associated with improved OS.
• Clear benefit observed in PD-L1 ≥1% group.
Image
🤖 Oncology - L3 Skeletal Muscle Index in CT Imaging
This article discusses a new e-abstract published at ASCO25, examining the technical performance of the L3 Skeletal Muscle Index (SMI) in CT imaging. The study focuses on the reliability and accuracy of L3 SMI as a muscle mass biomarker in oncology.
Key Points:
• Evaluation of L3 SMI reliability and accuracy in CT imaging.
• L3 SMI is a key muscle mass biomarker relevant to oncology outcomes.
• Published as an e-abstract at ASCO25.
🔗 Resources:
• ASCO Abstract ↗ - Study details
✨ Healthcare - AliveCor and British Heart Foundation Partnership
This article announces a partnership between AliveCor and the British Heart Foundation to fund cardiovascular disease research. A portion of the proceeds from KardiaMobile 6L sales in the UK will be donated.
Key Points:
• Partnership to fund cardiovascular disease research.
• Donation from KardiaMobile 6L sales in the UK.
• Shared values between AliveCor and the British Heart Foundation.
Image
🤖 Healthcare - Abridge AI in Healthcare
This article summarizes a discussion with Abridge's CTO and Co-Founder, Professor Zachary Lipton, on the company's advanced AI in healthcare. It touches on team structure and the development of high-performing technology.
Key Points:
• Unique team structure for developing high-performing AI.
• Focus on outperforming technology in healthcare.
• Discussion by Abridge's CTO and Co-Founder.
Image
🚀 Healthcare - Cradlewise Smart Crib Expansion
This article discusses the expansion of Cradlewise, a smart crib startup using AI to improve infant sleep, into the Indian market. The company's journey from Bengaluru to the US and its subsequent return to India is highlighted.
Key Points:
• Expansion of Cradlewise into the Indian market.
• AI-powered technology for predicting and soothing infant sleep disturbances.
• Success in the US market precedes Indian expansion.
Image
✨ Healthcare - Dr. Lilly Jay Joins MyRileyApp
This article announces that Dr. Lilly Jay has joined MyRileyApp's Clinical Advisory Board. Dr. Jay is a clinical perinatal psychologist and advocate for maternal mental health.
Key Points:
• Dr. Lilly Jay joins MyRileyApp's Clinical Advisory Board.
• Strengthened focus on maternal mental health.
• Expertise in perinatal psychology added to the advisory board.
Image
🤖 Pathology - Ibex MedAx at SEAP-IAP Congress
This article discusses Ibex MedAx's participation in the 32nd National Congress of SEAP-IAP in San Sebastian, Spain. The company showcased its AI solutions for pathology.
Key Points:
• Ibex MedAx presence at the SEAP-IAP congress.
• Engagement with customers and partners.
• Showcasing AI solutions in pathology.
Image
Image
Image
⭐️ Support
If you liked reading this report, please star ⭐️ this repository and follow me on Github ↗, 𝕏 (previously known as Twitter) ↗ to help others discover these resources and regular updates.
